Fate Therapeutics
FATE
#7575
Rank
S$0.36 B
Marketcap
$3.18
Share price
-7.03%
Change (1 day)
17.66%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$2.99

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.90. In 2022 the company made an earnings per share (EPS) of -$3.89 a decrease over its 2021 EPS that were of -$2.98.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.99-23.12%
2022-$3.8930.49%
2021-$2.987.21%
2020-$2.7845.45%
2019-$1.9119.17%
2018-$1.6117.65%
2017-$1.36-3.77%
2016-$1.42-12.4%
2015-$1.62-3.97%
2014-$1.69-2.09%
2013-$1.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$10.48 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.43-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$11.57 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.15 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.62-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA